| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Revenue From Operations | 819.37 | 665.90 | 556.97 | 450.70 |
| Sale of Products | 815.12 | 655.61 | 553.49 | 438.82 |
| Sale of Services | 0.99 | 1.05 | 0.77 | 0.46 |
| Income from Investment and Financial Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Fixed Assets | 634.51 | 573.09 | 583.70 | 670.45 |
| Property, Plant and Equipments | 618.92 | 572.71 | 583.37 | 670.08 |
| Right-of-Use Assets | 0.67 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.64 | 0.39 | 0.34 | 0.37 |
| Market Cap (Rs in Crs) | 4,097.60 | |
|---|---|---|
| P/E | 36.64 | |
| Book Value (Rs) | 250.68 | |
| Div (%) | 0 | |
| Market Lot | 1 | |
| EPS (TTM) | 22.05 | |
|---|---|---|
| Price/Book | 3.22 | |
| Div Yield.(%) | 0 | |
| Face value (RS) | 10 | |
| Deliverables (%) | 41.45 | |
| Company Name | Market Cap (₹) | LTP (₹) | Prev. Close (₹) | Chg(%) |
52 Week H/L(₹)
|
|---|---|---|---|---|---|
| Sun Pharmaceuti... | 4,28,725.17 | 1,786.85 | 1,804.50 | -0.98 | 1,960.20 - 1,376.75 |
| Divis Laborator... | 1,59,525.38 | 6,009.20 | 6,215.55 | -3.32 | 6,448.75 - 3,725.55 |
| Cipla Ltd | 1,23,201.99 | 1,525.50 | 1,551.30 | -1.66 | 1,702.00 - 1,310.05 |
| Torrent Pharmac... | 1,09,514.33 | 3,235.95 | 3,324.25 | -2.66 | 3,589.95 - 2,513.05 |
| Mankind Pharma ... | 1,05,275.60 | 2,551.65 | 2,602.80 | -1.97 | 3,050.00 - 1,910.10 |
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others
| Category | No. of Shares | Percentage |
|---|---|---|
| Total Foreign | 15,62,224 | 3.08 |
| Total Institutions | 1,01,93,529 | 20.10 |
| Total Govt Holding | 0 | 0.00 |
| Total Non Promoter Corporate Holding | 6,82,077 | 1.35 |
| Total Promoters | 3,54,19,957 | 69.84 |
| Total Public & others | 2861318 | 5.65 |
| Total | 5,07,19,105 | 100 |
